WideTrial to Support Cost Recovery for Personalized Cancer Vaccine Trial and Expanded Access Program

Basket trial of neoantigen synthetic long peptide vaccines for patients with advanced malignancy, run by the Jaime Leandro Foundation in association with Washington University of St. Louis SAN FRANCISCO, Aug. 31, 2022 /PRNewswire/ -- WideTrial, Inc. will provide key regulatory support to...

Click to view original post